China Gives Conditional Approval for Its First Self-Developed Alzheimer’s Drug
Posted by
www.biotecnika.org
China Approves its First Alzheimer's Drug Oligomannate China has now
granted conditional approval to its first self-developed drug for
Alzheimer's disease, a move that may point to revived opportunities in
a therapeutic area where drugmakers have burned billions of dollars
without yielding a validated new drug. Oligomannate, which uses an
extract from marine brown algae […]
The post China Gives Conditional Approval for Its First Self-Developed
Alzheimer's Drug appeared first on BioTecNika .
https://www.biotecnika.org/2019/11/china-approves-its-first-alzheimers-drug-oligomannate/
Biotech News
Subscribe to:
Post Comments (Atom)
Post a Comment